Common Stock, Shares, Outstanding of Fulgent Genetics, Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fulgent Genetics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q3 2016 to Q3 2025.
  • Fulgent Genetics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 30,854,000, a 1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 30,854,000 +317,000 +1% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 30,608,000 +346,000 +1.1% 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 30,621,000 +731,000 +2.4% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 30,841,000 +1,188,000 +4% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 30,537,000 +502,000 +1.7% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 30,262,000 +345,000 +1.2% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 29,890,000 +198,000 +0.67% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 29,653,000 +215,000 +0.73% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 30,035,000 +354,000 +1.2% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 29,917,000 -349,000 -1.2% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 29,692,000 -635,000 -2.1% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 29,438,000 -722,000 -2.4% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 29,681,000 -148,000 -0.5% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 30,266,000 +753,000 +2.6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 30,327,000 +1,338,000 +4.6% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 30,160,000 +1,982,000 +7% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 29,829,000 +6,522,000 +28% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 29,513,000 +7,703,000 +35% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 28,989,000 +7,317,000 +34% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 28,178,000 +6,695,000 +31% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 23,307,000 +4,634,000 +25% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 21,810,000 +3,417,000 +19% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 21,672,000 +3,386,000 +19% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 21,483,000 +3,311,000 +18% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 18,673,000 +616,000 +3.4% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 18,393,000 +430,000 +2.4% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 18,286,000 +410,000 +2.3% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 18,172,000 +325,000 +1.8% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 18,057,000 +286,000 +1.6% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 17,963,000 +223,000 +1.3% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 17,876,000 +195,000 +1.1% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 17,847,000 +171,000 +0.97% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 17,771,000 +4,925,000 +38% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 17,740,000 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 17,681,000 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 17,676,000 31 Dec 2016 10-K 20 Mar 2018 2017 FY
Q3 2016 12,846,000 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.